111, Inc. ADR logo

111, Inc. ADR (8110)

Market Closed
17 Jul, 20:00
3. 14
-0.06
-1.875%
- Market Cap
- P/E Ratio
- Div Yield
1,516 Volume
0 Eps
3.2
Previous Close
Add Transaction
Day Range
3.14 3.14
Year Range
2.08 6.75
Want to track 8110 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

8110 closed yesterday lower at €3.14, a decrease of -1.875% from Thursday's close, completing a monthly decrease of -12.7778% or -€0.46. Over the past 12 months, 8110 stock gained 50.9615%.
8110 is not paying dividends to its shareholders.
The last earnings report, released on Mar 19, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
111, Inc. ADR has completed 1 stock splits, with the recent split occurring on Jan 24, 2025.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

8110 Chart

111, Inc. (YI) Q4 2024 Earnings Call Transcript

111, Inc. (YI) Q4 2024 Earnings Call Transcript

111, Inc. (NASDAQ:YI ) Q4 2024 Earnings Conference Call March 20, 2025 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Robert Sassoon - Water Tower Research Shifan Sun - CICC Zoe Bian - Citi Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.

Seekingalpha | 1 year ago
111, Inc. (YI) Q3 2024 Earnings Call Transcript

111, Inc. (YI) Q3 2024 Earnings Call Transcript

111, Inc. (NASDAQ:YI ) Q3 2024 Results Conference Call November 27, 2024 7:30 AM ET Company Participants Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the Company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.

Seekingalpha | 1 year ago
111, Inc. (YI) Q2 2024 Earnings Call Transcript

111, Inc. (YI) Q2 2024 Earnings Call Transcript

111, Inc. (NASDAQ:YI ) Q2 2024 Earnings Conference Call August 29, 2024 7:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, 111's Major Subsidiary Conference Call Participants Xipeng Feng - CICC Zoe Bian - Citi Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.

Seekingalpha | 1 year ago

111, Inc. ADR (8110) FAQ

What is the stock price today?

The current price is €3.14.

On which exchange is it traded?

111, Inc. ADR is listed on XFRA.

What is its stock symbol?

The ticker symbol is 8110.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has 111, Inc. ADR ever had a stock split?

111, Inc. ADR had 1 splits and the recent split was on Jan 24, 2025.

111, Inc. ADR Profile

Pharmaceuticals Industry
Healthcare Sector
Junling Liu CEO
XFRA Exchange
68247Q201 CUSIP
CN Country
1,238 Employees
- Last Dividend
- Last Split
12 Sep 2018 IPO Date

Overview

111, Inc., is a prominent entity in the healthcare market of the People's Republic of China, leveraging an innovative blend of online and offline platforms to serve a wide spectrum of health-related consumer needs. Operating through two distinct segments, B2C (Business to Consumer) and B2B (Business to Business), the company distinguishes itself by offering a comprehensive range of medical and wellness products alongside value-added services. It aims at streamlining the procurement of healthcare products and enhancing accessibility to healthcare services for consumers across China. Founded in 2010 and undergoing a name change from New Peak Group to 111, Inc. in April 2018, the company positions itself as a key player in transforming the healthcare landscape by integrating digital solutions. With its headquarters in Shanghai, it extends its services across various Chinese provinces through both its online platforms and offline Yi Hao Pharmacy stores.

Products and Services

Medical and Wellness Products: 111, Inc. offers an extensive range of medical products through its online retail, and wholesale and retail pharmacies. This includes:

  • Prescription Drugs: A selection of essential medications that cater to various health conditions, ensuring customers have access to their prescribed treatments.
  • Over-The-Counter Drugs: Easily accessible medications for common ailments, promoting self-care among consumers.
  • Traditional Chinese Medicines (TCM): Offering a holistic approach to health, these products embrace the rich heritage of Chinese medicinal practices.
  • Nutritional Supplements: Catering to the growing awareness and need for dietary supplements including vitamins and dietary products to support overall health and wellness.
  • Contact Lenses: Addressing visual impairments with a range of contact lenses for daily wear.
  • Medical Supplies and Devices: Critical tools for health monitoring and care, such as bandages and thermometers, ensuring preparedness for various healthcare needs.
  • Personal Care Products: A selection of products supporting personal hygiene and care, including skin care, birth control, sexual wellness products, and baby products.

Value-Added Services: Beyond product offerings, 111, Inc. enhances its value proposition through several service offerings. These include:

  • Online Consultation Services: Facilitating digital access to healthcare professionals for advice, consultations, and diagnosis, prioritizing customer convenience and care.
  • Electronic Prescription Services: Digitizing prescriptions to streamline the medication procurement process, improving efficiency and reducing paperwork.
  • Online Marketplace: An innovative platform where third-party sellers directly engage with pharmacies, enhancing selection and accessibility for end consumers.
  • Loan Application Services: Providing financial support services via online loan applications for pharmacies and wholesalers, aiding them in expanding their inventory and services.
  • Data and Supply Chain Integration: Offering sophisticated data analysis and supply chain solutions to optimize operations for pharmacies and pharmaceutical companies.
  • Warehousing, Logistics, and More: Comprehensive support services including warehousing, logistics, procurement, R&D, consulting, software development, and IT support, catering to a wide range of operational needs within the healthcare sector.

Contact Information

Address: No.295 ZuChongZhi Road
Phone: 86 21 2053 6666